| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 32 |
| 1 | INFLIXIMAB | 31 |
| 2 | METHOTREXATE | 28 |
| 3 | PREDNISONE | 27 |
| 4 | TOCILIZUMAB | 27 |
| 5 | VALACYCLOVIR | 24 |
| 6 | VALACYCLOVIR HYDROCHLORIDE | 24 |
| 7 | RIVAROXABAN | 22 |
| 8 | FOLIC ACID | 20 |
| 9 | RITUXIMAB | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LOXAPINE | 7 | 0.0018 |
| 1 | FOSPHENYTOIN SODIUM | 4 | 0.0015 |
| 2 | GOLIMUMAB | 16 | 0.0013 |
| 3 | DINUTUXIMAB | 1 | 0.0012 |
| 4 | ALBUMIN HUMAN | 4 | 0.0008 |
| 5 | ALBUMIN (HUMAN) | 4 | 0.0007 |
| 6 | ISATUXIMAB | 4 | 0.0007 |
| 7 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 3 | 0.0007 |
| 8 | GIVOSIRAN SODIUM | 1 | 0.0006 |
| 9 | SELUMETINIB | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 64 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 37 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 3 | Proton Pump Inhibitor [EPC] | 30 |
| 4 | Factor Xa Inhibitor [EPC] | 28 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 28 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 27 |
| 7 | Vitamin C [EPC] | 27 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 21 |
| 9 | Vitamin B12 [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 2 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 3 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 4 | Asparagine-specific Enzyme [EPC] | 4 | 0.0003 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 27 | 0.0002 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 3 | 0.0002 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 2 | 0.0002 |
| 8 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 9 | Vitamin K [EPC] | 1 | 0.0001 |